Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phosphoramidite. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1646452A details a safer phosphitylation method using hindered amine activators, offering cost reduction and scalability for oligonucleotide manufacturing.
Novel synthesis method for high-purity phosphoramidite nucleoside derivatives enabling cost-effective oligonucleotide manufacturing and scalable supply chains for global pharmaceutical partners.
Novel one-pot synthesis method for high-purity nucleoside dimer phosphoramidites. Reduces steps and reagent costs for oligonucleotide manufacturing.
Patent CN102746338B reveals novel spiroketal ligands enabling high-selectivity hydroformylation. Discover cost-effective catalytic solutions for fine chemical manufacturing.
Patent CN1133641C details novel AZT prodrugs with enhanced antiviral activity. Offers scalable synthesis for pharmaceutical intermediates.
Patent CN112824421A reveals a robust chiral ligand synthesis route offering high enantioselectivity and TON up to 10000 for pharmaceutical manufacturing.
Novel phosphoramidite ligands offer high ee values and scalable synthesis for pharmaceutical intermediates manufacturing with significant cost advantages.